CVE-2023-38955
HIGHCVSS 7.5/10EPSS 0.50%
Last modified
CVE-2023-38955 is a high-severity vulnerability rated 7.5/10 on the CVSS scale. ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to obtain sensitive information about all managed devices, including their IP addresses and device names.. EPSS estimates a 0.50% chance of exploitation in the next 30 days.
Description
ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to obtain sensitive information about all managed devices, including their IP addresses and device names.
Metrics
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Zkteco | Bioaccess Ivs | 3.3.1 |
References
- http://zkteco.comNot Applicable
- https://claroty.com/team82/disclosure-dashboard/cve-2023-38955Third Party Advisory
- http://zkteco.comNot Applicable
- https://claroty.com/team82/disclosure-dashboard/cve-2023-38955Third Party Advisory
Timeline
- Published
- Last Modified
- Status
- Modified
Frequently Asked Questions
What is CVE-2023-38955?
ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to obtain sensitive information about all managed devices, including their IP addresses and device names.
How severe is CVE-2023-38955?
CVE-2023-38955 has a CVSS score of 7.5/10 (HIGH severity). The EPSS model estimates a 0.50% probability of exploitation in the next 30 days.
How do I fix CVE-2023-38955?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.
Are you affected by CVE-2023-38955?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST